Alternatives to EmbryoNet-AI

AI-guided drug discovery platform for tissue-targeted medicines.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Mapping cell-cell communication at scale in human tissue.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

AI-powered platform accelerating biological research and drug discovery.

Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

Developing engineered biologics to harness the immune system for disease treatment.

AI-driven drug discovery company developing novel medicines for unmet patient needs.